Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2018-03-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
关于2018年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from a company regarding its expected related party transactions for the fiscal year 2018. It includes details about the nature of the transactions, estimated amounts, related parties, pricing policies, and approvals from the board and independent directors. The document is not a full financial report, audit, or earnings release but rather a disclosure about anticipated related party dealings, which is a regulatory announcement. The document length is under 5,000 characters and it serves as an announcement of expected transactions rather than a detailed report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-03-15 Chinese
第三届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the third board of directors' fifth meeting of a company, including approval of the 2017 annual general manager's report, board report, full annual report, financial statements, profit distribution plan, internal control reports, related party transactions, financing credit applications, and changes to registered capital and company bylaws. It includes voting results and references to reports disclosed on official information platforms. The document is not the annual report itself but a board meeting resolution announcement that discusses and approves the annual report and related financial data, and it states that these reports are disclosed elsewhere. The document also includes agenda items to be submitted to the 2017 annual general meeting for approval. This type of document is best classified as Board/Management Information (MANG) because it announces board meeting decisions and management reports rather than being the full annual report or a simple announcement of report publication.
2018-03-15 Chinese
2017年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report for the fiscal year ending December 31, 2017, issued by a registered accounting firm (瑞华会计师事务所). It contains detailed audit opinions, basis for audit, key audit matters, management responsibilities, and extensive financial statements including consolidated balance sheets, income statements, cash flow statements, and equity changes. The presence of detailed financial data and audit opinions indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document length is substantial (15,000 characters), and it includes comprehensive financial statements and notes. Therefore, it fits the category of an Audit Report / Information (AR). FY 2017
2018-03-15 Chinese
监事会关于《公司2017年度内部控制自我评价报告》审核意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board's audit opinion on the company's 2017 internal control self-evaluation report. It references legal and regulatory frameworks and confirms the adequacy and effectiveness of internal controls. The document is short (500 characters) and serves as an audit or review statement rather than the full internal control report itself. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles, excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2017
2018-03-15 Chinese
2017年度独立董事述职报告（林瑞超）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2017 from a company. It details the independent director's attendance at board meetings, opinions on management appointments, accounting policy changes, and other governance-related activities. There is no indication of full financial statements or comprehensive financial performance data. The content focuses on the independent director's duties, opinions, and governance oversight rather than financial results or audit findings. This type of document aligns with Board/Management Information filings, which cover announcements related to board members and senior management activities and reports. The document length is 3126 characters, which is relatively short and consistent with a report or statement rather than a full annual or interim report. Therefore, the most appropriate classification is Board/Management Information (MANG).
2018-03-15 Chinese
关于2018年度向银行申请综合授信额度并对子公司授信额度内贷款提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding its application for a comprehensive credit line from banks and the provision of guarantees for loans within the credit limits to its subsidiaries. It details the credit amounts requested, the guarantee amounts, the basic information of the subsidiaries receiving guarantees, and the board's approval of the credit and guarantee proposal. There are no financial statements or detailed financial performance data presented; rather, it is a disclosure of financing activities and guarantees. The document length is about 4500 characters, which is relatively short and focused on a specific financing update. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is CAP with high confidence.
2018-03-15 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.